Pathovax

Prophylactic vaccine against all 15 oncogenic human papillomavirus.

placeBaltimore, Maryland, United States calendar_todayFounded 2014 groups3 employees language pathovax.com

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Accelerator & incubator240%
Other / undisclosed240%
Coming soon